CLCellebrite DI Ltd. CLBT · NASDAQ
$11.79 +2.52% (+$0.29)
- Market cap
- $2.96B
- Enterprise value
- $2.85B
- P/E
- 50.4x
- Forward P/E
- 43.0x
- PEG
- -
- P/S
- 5.8x
- P/FCF
- 21.2x
- EV/EBITDA
- 25.0x
- ROIC
- 6.9%
- Gross margin
- 83.0%
- Net margin
- 11.4%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -1.0x
- Beta
- 1.13
- Free float
- 50.0%
About the company
Cellebrite DI Ltd. (CLBT) is an Israeli technology company specializing in digital intelligence and forensic analysis. The company provides advanced tools and solutions for extracting, analyzing, and managing digital data, assisting law enforcement agencies, government organizations, and businesses in obtaining valuable insights from digital devices. Cellebrite is renowned for its cutting-edge technologies that enable swift and effective investigations of cybercrimes, fraud, and other digital threats. The company focuses on innovation and the continuous development of its products to meet the needs of its clients. Cellebrite DI Ltd. (CLBT) shares could be suitable for investors looking for opportunities in cybersecurity and digital forensic analysis.
Sector
Technology
Industry
Software - Infrastructure
CEO
Shiv Ramji
Employees
1,285
Headquarters
Petah Tikva
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number